Mirae Asset Global ETFs Holdings’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
OFM
DFO
Mirae Asset Global ETFs Holdings's NUVB Position: Q2 2026 in Review
Mirae Asset Global ETFs Holdings increased its Nuvation Bio (NUVB) stake by 2.7% in Q2 2026, buying an estimated $14.9K and bringing the position to 116,065 shares worth $659K. The position accounts for ﹤0.01% of the portfolio, ranked #1853.
Mirae Asset Global ETFs Holdings first reported a position in NUVB in Q2 2024 and has held it in 9 quarters since. The position peaked at $1M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- Mirae Asset Global ETFs Holdings held 116,065 shares of Nuvation Bio worth $659K as of Q2 2026.
- Mirae Asset Global ETFs Holdings bought 3,045 Nuvation Bio shares in Q2 2026, an estimated $14.9K.
- Nuvation Bio made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1853 holding.
- Mirae Asset Global ETFs Holdings first reported a position in Nuvation Bio in Q2 2024 and has held it in 9 quarters since.
- Mirae Asset Global ETFs Holdings's Nuvation Bio position peaked at $1M in Q4 2025.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.